Article révisé par les pairs
Titre:
  • Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
Auteur:Hendlisz, Alain; Golfinopoulos, Vassilis; Deleporte, Amélie; Paesmans, Marianne; Mansy, Hazem El; Garcia, Camilo; Peeters, Michel; Annemans, Lieven; Vandeputte, Caroline; Maetens, Marion M.; Borbath, Ivan; Dresse, Damien; Houbiers, Ghislain; Fried, Michael; Awada, Ahmad; Piccart-Gebhart, Martine; Van Laethem, Jean-Luc; Flamen, Patrick
Informations sur la publication:BMC cancer, 13, 190
Statut de publication:Publié, 2013-04
Sujet CREF:Cancérologie
Biologie
Mots-clés:Adjuvant
Chemosensitivity
Colon cancer
Early assessment
FDG-PET
PET/CT
MeSH keywords:Adenocarcinoma -- drug therapy -- mortality -- pathology
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Belgium
Chemotherapy, Adjuvant
Colonic Neoplasms -- drug therapy -- mortality -- pathology
Fluorouracil -- therapeutic use
Follow-Up Studies
Gene Rearrangement
Humans
Leucovorin -- therapeutic use
Lymphocytes, Tumor-Infiltrating
Neoplasm Staging
Neoplastic Cells, Circulating -- pathology
Organoplatinum Compounds -- therapeutic use
Polymorphism, Single Nucleotide -- genetics
Positron-Emission Tomography
Preoperative Care
Prognosis
Prospective Studies
Quality of Life
Survival Rate
Tomography, X-Ray Computed
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1471-2407
info:doi/10.1186/1471-2407-13-190
info:pii/1471-2407-13-190
info:scp/84877068204
info:pmid/23587148
PMC3637567

Documents en relation

DI-fusion